Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
Close filters
Filter by:
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
from to

Products from TargetMol

TargetMol

TargetMol, based in Boston, Massachusetts, was founded in 2015 and is a drug screening expert in the life science community. The company offers diverse compound libraries, including FDA-approved libraries, and covers a broad spectrum of small molecule compounds such as inhibitors and agonists as well as recombinant proteins and natural products. TargetMol's products are used by researchers worldwide in areas such as cancer research, neurobiology, inflammation, immunology and metabolism.

More information at: www.targetmol.com

Go to the catalogs of TargetMol

Filter
10582 from 11319 pages
No results were found for the filter!
KDOAM-25 trihydrochloride
KDOAM-25 trihydrochloride

Item number: TGM-T62166-100mg

TargetMol
Description: KDOAM-25 trihydrochloride is a potent and highly selective inhibitor of histone lysine demethylase 5 (KDM5), targeting KDM5A (IC50: 71 nM), KDM5B (IC50: 19 nM), KDM5C (IC50: 69 nM), and KDM5D (IC50: 69 nM). It enhances overall H3K4 methylation at the transcription start site and hinders the...
MW: 416.77 D
From 1,440.00€ *
Show details
Review
Dual AChE-MAO B-IN-1
Dual AChE-MAO B-IN-1

Item number: TGM-T62172-100mg

TargetMol
Description: Dual AChE-MAO B-IN-1 (compound 15) is a safe, metabolically stable neuroprotective agent. This potent, orally active, CNS-permeable inhibitor demonstrates IC50 values of 550 nM for human AChE and 8.2 nM for MAO-B, indicating low in vitro activity against these enzymes. Target: Others
MW: 417.45 D
From 1,440.00€ *
Show details
Review
COX-2-IN-8
COX-2-IN-8

Item number: TGM-T62175-100mg

TargetMol
Description: COX-2-IN-8 (Compound 6a) is a potent, selective, orally active COX-2 inhibitor (IC50: 6.585 µM) with a higher COX-2 selectivity than Celecoxib. Target: Others
MW: 417.5 D
From 1,440.00€ *
Show details
Review
TLR7/8 antagonist 1
TLR7/8 antagonist 1

Item number: TGM-T62178-100mg

TargetMol
Description: TLR7/8 Antagonist 1 (Compound 16c), an imidazoquinoline derivative, is a potent TLR7/8 agonist with IC50 values of 3.91 and 2.19 µM for TLR7 and TLR8, respectively. rel-O-2050 (TLR-2050) is a key target for drug development in infectious diseases, cancer, and autoimmune diseases. Target: Others
MW: 417.5 D
From 1,440.00€ *
Show details
Review
ART615
ART615

Item number: TGM-T62186-100mg

TargetMol
Description: ART615 is a related isomer of ART558. ART615 inhibits Poltheta by <10% at 12 µM and is able to act as a control for ART558 (IC50:7.9 nM). Target: Others
MW: 418.41 D
From 1,440.00€ *
Show details
Review
ATR-IN-12
ATR-IN-12

Item number: TGM-T62563-100mg

TargetMol
Description: ATR-IN-12 (Compound 5g) is a potent inhibitor of ataxia-capillaris and Rad3-related (ATR) kinase with an IC50 of 0.007 µM, making it a promising lead compound for further drug discovery studies on ATR kinases. Target: Others
MW: 441.55 D
From 1,440.00€ *
Show details
Review
CDK2-IN-9
CDK2-IN-9

Item number: TGM-T62567-100mg

TargetMol
Description: CDK2-IN-9 is a potent CDK2 inhibitor (IC50: 0.63 µM) with anti-proliferative effects, capable of blocking the cell cycle in S and G2/M phases and inducing apoptosis, showing potential for melanoma research. Target: Others
MW: 441.89 D
From 1,440.00€ *
Show details
Review
Antileishmanial agent-6
Antileishmanial agent-6

Item number: TGM-T62574-100mg

TargetMol
Description: Antileishmanial agent-6 is a potent anti-leishmanial agent with anti-leishmanial activity (IC50: 0.54 µM) and cytotoxicity (IC50: 10.2 µM) against Leishmania donovani and L-6. Target: Others
MW: 442.46 D
From 1,440.00€ *
Show details
Review
Anti-ToCV agent 1
Anti-ToCV agent 1

Item number: TGM-T62575-100mg

TargetMol
Description: Anti-ToCV agent 1 [AIDA] can be used as a potential anti-ToCV drug. Target: Others
MW: 442.46 D
From 1,440.00€ *
Show details
Review
CBR Agonist-1
CBR Agonist-1

Item number: TGM-T62583-100mg

TargetMol
Description: CBR Agonist-1 (27a-cis) is a cannabinoid receptor (CBR) agonist that targets CB1R with a Ki of 0.18 µM and CB2R with a Ki of 1.22 µM. It can be utilized to investigate diseases related to the endogenous cannabinoid system. Target: Others
MW: 442.53 D
From 1,440.00€ *
Show details
Review
CBR Agonist-2
CBR Agonist-2

Item number: TGM-T62584-100mg

TargetMol
Description: CBR Agonist-2 is a CB1 agonist (CB1R, CB1 ligand) with an EC50 of 960 nM and Ki of 970 nM, making it a promising tool for studying diseases related to the endogenous cannabinoid system involving hCB1R. Target: Others
MW: 442.53 D
From 1,440.00€ *
Show details
Review
Cav 2.2/3.2 blocker 1
Cav 2.2/3.2 blocker 1

Item number: TGM-T62586-100mg

TargetMol
Description: Cav 2.2/3.2 blocker 1 (Compound 9e) is a neuronal calcium channel blocker with IC50 values of 1.22 µM for Cav2.2 and 80 µM for Cav3.2, capable of penetrating the central nervous system. Target: Others
MW: 442.55 D
From 1,440.00€ *
Show details
Review
10582 from 11319 pages
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the usability of this website, serve for direct advertising or simplify interaction with other websites and social networks, will only be used with your consent. More information
Decline Accept all Configure